secwatch.observer — SEC 8-K summary
======================================

Issuer:     VivoSim Labs, INC. (VIVS)
CIK:        0001497253
Form:       8-K
Filed at:   2023-08-22T23:59:59+00:00
Accession:  0001193125-23-218056
Event type: leadership
Sentiment:  negative
Materiality: 0.75
Item codes: 2.05, 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Organovo reduces workforce by 24% and terminates General Counsel and CSO to focus on FXR314
--------------------------------------------------------------------------------

- Workforce reduced by ~6 employees (~24% of staff) effective Aug 25, 2023 to focus on clinical drug FXR314.
- Tom Jurgensen (General Counsel & Corporate Secretary) and Jeffrey Miner (CSO) terminated; last day Aug 25, 2023.
- Company expects to enter consulting agreement with Dr. Miner for post-termination services.
- Severance charges not yet estimable; will amend filing once determined.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1497253/000119312523218056/0001193125-23-218056-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1497253/000119312523218056/d434452d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-218056

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer